Intra-Cellular Therapies
-$0.77 (-1.32%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITCI and other ETFs, options, and stocks.
About ITCI
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS.
CEO
Sharon Mates
Employees
512
Headquarters
New York, New York
Founded
2002
ITCI Key Statistics
Market cap
5.45B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.39M
High today
$60.64
Low today
$57.39
Open price
$58.50
Volume
930.84K
52 Week high
$66.00
52 Week low
$28.40
Analyst ratings
92%
of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%
ITCI Earnings
-$1.05
-$0.92
-$0.78
-$0.65
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.92 per share
Actual
-$0.78 per share